Related Experiment Video

Updated: Jun 18, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Activity and cellular localization of an oncogenic glioblastoma multiforme-associated EGF receptor mutant possessing

B H Ozer1, G J Wiepz, P J Bertics

  • 1Department of Biomolecular Chemistry, University of Wisconsin, Madison, WI 53706, USA.

Oncogene
|November 17, 2009
PubMed

Insights

A novel epidermal growth factor receptor (EGFR) mutation causing tandem kinase domain duplication (TKD-EGFR) leads to constitutive activation in glioblastoma. This mutated EGFR bypasses normal downregulation, driving tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Glioblastoma multiforme (GBM) is a deadly brain cancer.
  • Epidermal growth factor receptor (EGFR) mutations, including tandem kinase domain duplication (TKD-EGFR), are implicated in GBM tumorigenicity.
  • The precise molecular mechanisms driving TKD-EGFR dysregulation remain unclear.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying TKD-EGFR activation and dysregulation.
  • To investigate the contribution of each duplicated kinase domain to receptor phosphorylation and activity.
  • To understand how TKD-EGFR escapes normal cellular downregulation pathways.

Main Methods:

  • Transfection of EGFR-null B82L mouse fibroblast cells with TKD-EGFR.
  • Analysis of basal autophosphorylation at key phosphotyrosine sites.
  • Assessment of ligand-binding inhibition and receptor dimerization.
  • Immunofluorescence microscopy to determine subcellular localization.
  • Generation and analysis of kinase activity-deficient TKD-EGFR mutants.

Main Results:

  • TKD-EGFR exhibits elevated basal autophosphorylation at five phosphotyrosine sites.
  • The mutated receptor is resistant to ligand-binding inhibition and shows minimal basal dimerization.
  • A significant portion of TKD-EGFR localizes to the cytosol in an activated state.
  • Mutational analysis revealed distinct roles for the N-terminal and C-terminal kinase domains in constitutive activation.

Conclusions:

  • TKD-EGFR possesses a unique mechanism for constitutive activation driven by dual kinase domain engagement.
  • The mutated receptor evades canonical downregulation, contributing to its oncogenic potential in glioblastoma.
  • Understanding TKD-EGFR activation provides insights into novel therapeutic strategies for EGFR-driven cancers.

More Related Videos

Assaying Protein Kinase Activity with Radiolabeled ATP08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing09:24

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

Published on: June 9, 2016

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...